File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/cea.70014
- Scopus: eid_2-s2.0-86000056621
- Find via

Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Hereditary Angioedema (HAE) in China: Advancing Awareness, Access, Advocacy and Alliances From the Greater Bay Area to the Global HAE Community
| Title | Hereditary Angioedema (HAE) in China: Advancing Awareness, Access, Advocacy and Alliances From the Greater Bay Area to the Global HAE Community |
|---|---|
| Authors | |
| Keywords | access advocacy alliance angioedema awareness China Greater Bay Area hereditary |
| Issue Date | 4-Mar-2025 |
| Publisher | Wiley |
| Citation | Clinical & Experimental Allergy, 2025 How to Cite? |
| Abstract | The article offers an overview of the progress in managing Hereditary Angioedema (HAE) in China, with a specific focus on the Greater Bay Area (GBA). Through the ‘4As’ framework—Awareness, Access, Advocacy and Alliance—the article explores the challenges and advancements in HAE care. In terms of collaborative initiatives such as the HAE-ASIA (Angioedema Screening In Asia) collaboration and the GBA HAE Alliance “Hub-and-Spoke model” aim to bridge the gap between East and West, providing optimal patient care and advancing HAE management. By bridging the gap between East and West, the GBA aims to deliver optimal patient care and advance HAE management. Moving forward, it will be essential to persist in nurturing national and international collaborations, not only within China but also extending beyond its borders. These partnerships encourage the exchange of knowledge, research, and best practices, all of which are critical in propelling forward the care of HAE. By uniting as a worldwide community, we can significantly advance efforts to improve the quality of life for those affected by HAE across the globe. |
| Persistent Identifier | http://hdl.handle.net/10722/357458 |
| ISSN | 2023 Impact Factor: 6.3 2023 SCImago Journal Rankings: 1.290 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Li, Philip H. | - |
| dc.contributor.author | Huang, Jin Xian | - |
| dc.contributor.author | Wang, Can Tian | - |
| dc.contributor.author | Wong, Jane C.Y. | - |
| dc.contributor.author | Chen, Hao | - |
| dc.contributor.author | Chai, Bao | - |
| dc.contributor.author | Chen, Liang | - |
| dc.contributor.author | Lai, He | - |
| dc.contributor.author | Li, Shuo | - |
| dc.contributor.author | Liang, Yan Hua | - |
| dc.contributor.author | Liang, Yun Sheng | - |
| dc.contributor.author | Liu, Ning | - |
| dc.contributor.author | Lu, Bing | - |
| dc.contributor.author | Sun, Bao Qing | - |
| dc.contributor.author | Yang, Qin Tai | - |
| dc.contributor.author | Ye, Fei | - |
| dc.contributor.author | Zhang, Jiang Lin | - |
| dc.contributor.author | Zhang, Shu Chen | - |
| dc.contributor.author | Zhao, Zuo Tao | - |
| dc.contributor.author | Zhou, Min | - |
| dc.contributor.author | Zou, Xian Biao | - |
| dc.contributor.author | Liu, Guang Hui | - |
| dc.contributor.author | Guan, Kai | - |
| dc.date.accessioned | 2025-07-22T03:12:52Z | - |
| dc.date.available | 2025-07-22T03:12:52Z | - |
| dc.date.issued | 2025-03-04 | - |
| dc.identifier.citation | Clinical & Experimental Allergy, 2025 | - |
| dc.identifier.issn | 0954-7894 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/357458 | - |
| dc.description.abstract | The article offers an overview of the progress in managing Hereditary Angioedema (HAE) in China, with a specific focus on the Greater Bay Area (GBA). Through the ‘4As’ framework—Awareness, Access, Advocacy and Alliance—the article explores the challenges and advancements in HAE care. In terms of collaborative initiatives such as the HAE-ASIA (Angioedema Screening In Asia) collaboration and the GBA HAE Alliance “Hub-and-Spoke model” aim to bridge the gap between East and West, providing optimal patient care and advancing HAE management. By bridging the gap between East and West, the GBA aims to deliver optimal patient care and advance HAE management. Moving forward, it will be essential to persist in nurturing national and international collaborations, not only within China but also extending beyond its borders. These partnerships encourage the exchange of knowledge, research, and best practices, all of which are critical in propelling forward the care of HAE. By uniting as a worldwide community, we can significantly advance efforts to improve the quality of life for those affected by HAE across the globe. | - |
| dc.language | eng | - |
| dc.publisher | Wiley | - |
| dc.relation.ispartof | Clinical & Experimental Allergy | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | access | - |
| dc.subject | advocacy | - |
| dc.subject | alliance | - |
| dc.subject | angioedema | - |
| dc.subject | awareness | - |
| dc.subject | China | - |
| dc.subject | Greater Bay Area | - |
| dc.subject | hereditary | - |
| dc.title | Hereditary Angioedema (HAE) in China: Advancing Awareness, Access, Advocacy and Alliances From the Greater Bay Area to the Global HAE Community | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1111/cea.70014 | - |
| dc.identifier.scopus | eid_2-s2.0-86000056621 | - |
| dc.identifier.eissn | 1365-2222 | - |
| dc.identifier.issnl | 0954-7894 | - |
